- Name: Atriance
- Generic Name: Nelarabine
- Strength: 250 mg/50 ml (5 mg/ml) Vial.
- Manufactured : Novartis Pharmaceuticals
Atriance is a nucleoside metabolic inhibitor used for the treatment of patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma whose disease has not responded to or has relapsed after treatment with at least two chemotherapy regimens.
Note: Atriance (Nelarabine) is an FDA approved drug.
Indian Pharma Network is a rapidly expanding pharmaceutical consulting and service organization that offers genuine pharmaceuticals through a dependable network of pharmacies, suppliers, and distributors.